Superficial peels in Fortaleza Brazil
Chemical peels are one of the most popular non-invasive cosmetic procedures performed to rejuvenate the appearance of the skin. Over time, factors such as sun damage, heredity, diet, and repetitive muscle movement contribute the formation of lines and wrinkles in the face. Additionally, the development of pigmentation irregularities or acne scars can cause skin to lose its smooth, youthful appearance. Often performed on the face, neck, and hands, various types of chemical peels can reduce the appearance of facial wrinkles, scars, and uneven pigmentation, as well as treat pre-cancerous skin lesions.
Superficial peels are the mildest form of chemical peel treatment. Superficial peels are usually performed using alphahydroxy acids, and in some instances betahydroxy acids. Alphahydroxy acids are naturally occurring acids which include glycolic acid, lactic acid, and fruit acids, while betahydroxy acids include salicylic acid. You may be familiar with glycolic acid and salicylic acid, as they are often key ingredients in facial creams and astringents. Although the concentration of acid may vary depending on the extent of treatment, the acids used to perform superficial peels are not as harsh as other chemical peels. In fact, low concentrations of alphahydroxy acids are often mixed with facial creams or washes that can be used as part of a daily facial care routine to maintain a youthful appearance. With little downtime, superficial peels are a safe, effective method of treating fine lines, pigmentation abnormalities, acne scars, and persistent dry skin.
The skin is composed of two layers know as the epidermis and dermis. The epidermis, or outer layer of the skin, acts as the skin’s primary defense against the environment. As a result, these layers are damaged. The dermis, or innermost layer of the skin, is composed primarily of connective tissue. Within the connective tissue of the dermis, collagen and elastin fibers form a network that provides the skin with structure, support, and elasticity. Over time, this network of fibers breaks down as well, which, in addition to other factors, further contributes to the formation of wrinkles and other changes in appearance.
During a superficial peel, a chemical solution is applied to the face. The solution causes mild trauma or injury to the epidermis, which is composed of five distinct layers. Similar to exfoliating your skin, the injury causes the damaged outer layers of the epidermis to peel away. As part of the healing process, increased cell growth produces new, healthier skin layers beneath, which give the face a more youthful, rejuvenated appearance.
It is important to realize that superficial peels are not intended to treat deep wrinkles or significantly sagging skin. In these circumstances, a face lift or dermal filler injections may produce more desirable results.
Often referred to as the “lunchtime peel,” superficial peels generally last between fifteen and thirty minutes. A few weeks before your procedure, your physician may recommend that you use a facial product that contains trans retinoic acid. This is because trans retinoic acid is believed to prepare the outer layer of skin for treatment as well as allow the chemical peel solution to soak evenly through your skin. You may also be required to wash your face with a special soap twenty four hours before your procedure.
Prior to the start of your procedure, the treatment areas will be cleansed, usually using an alcohol based cleaner. While you may feel a slight stinging or warming sensation during the procedure, you will most likely not feel any significant pain. Therefore, an anesthetic is usually not necessary for a superficial peel.
Using a sponge or a brush, the physician will apply the chemical solution to individual areas over the entire face. The solution will penetrate into your skin for approximately fifteen minutes and then it will be removed or neutralized with a different substance.
Superficial peels generally treat the epidermis, which is why the effects of treatment are less than other types of chemical peels. The chemical solution used during a superficial peel damages the outermost layers of the epidermis, which causes them to peel away. The healing process triggers cell growth which generates new skin layers. In addition, the healing process also stimulates collagen and elastin production in the dermis. As the damaged skin peels away, the new skin is revealed, giving the face a smoother, revitalized, more youthful appearance.
Immediately following your procedure, you may experience some redness and irritation that is similar to sunburn. As healing takes place, you may also notice some crusting or flaking of your skin. These symptoms will most likely subside in approximately seven days. Although bandaging is not necessary, like any wound it is important to keep the area moist and protected. Therefore, your physician may recommend that you apply a protective ointment to your face in the days following your procedure. You will most likely notice the outer layers of the skin peeling away within several days following treatment. New skin will begin to appear in approximately one to two weeks. Your skin will be more sensitive to sun exposure as it heals. Therefore, it is extremely important that you protect your skin from the sun with UVA and UVB protection while you heal.
The results from a superficial peel are generally mild compared to more aggressive forms of treatment such as a medium or deep peel. However, this also means that the risks associated with the procedure are typically less. Your physician may recommend that you undergo repeated treatments at regular intervals. For example, some individuals receive treatments on a weekly or monthly basis until the desired result is achieved.
It is important to realize that the appearance of your skin will continue to change and age after you have had a superficial peel treatment. However, superficial peels are a fast, effective method of rejuvenating your skin.
More Fortaleza info...
Fortaleza By air
The very modern International Airport Pinto Martins was opened in 1998. Airlines fly to almost everywhere in Brazil and also other capitals of South America. One daily flight to Miami, via Belem and Manaus, by TAM, one to Lisboa by TAP, and several weekly charters to major European airports, and even Cape Verde.
-
Fortaleza Cinemas
The largest complex at the Iguatemi-mall, with some 12 showrooms mostly displaying the latest fare from Hollywood. At Drag?o do Mar there's a more alternative selection. Oba has the full program for the city's cinemas.
-
Plastic Surgery News...
- According to research published in the Annals of Internal Medicine, glucosamine sulphate is no better than placebo in reducing symptoms and progression of hip osteoarthritis.
Researchers conducted a trial to assess whether glucosamine sulphate has an effect on the symptoms and structural progression of hip osteoarthritis during 2 years of treatment. The randomised, controlled trial involved 222 patients who met the American College of Rheumatology clinical criteria for hip osteoarthritis. Patients were randomised to receive 1500mg glucosamine sulphate or placebo once daily. Primary outcome measures were Western Ontario and McMaster Universities (WOMAC) pain and function subscales over 24 months and joint space narrowing after 24 months.
The following results were reported:
• WOMAC pain did not differ (mean difference –1.54 [95% CI, –5.43 to 2.36]), nor did WOMAC function (mean difference, –2.01 [CI, –5.38 to 1.36]).
• Joint space narrowing also did not differ after 24 months (mean difference, –0.029 [CI, –0.122 to 0.064]).
The authors conclude that glucosamine sulphate is not more effective than placebo in modifying the symptomatic and radiographic progression of hip osteoarthritis over 24 months of daily therapy. However, the authors also mention that their finding have limitations, as many study participants had total hip replacement during the study, and the numbers were not balanced between study groups, making interpretation of outcome measures in these patients difficult.
- The FDA has received a Biologics License Application for motavizumab, an investigational monoclonal antibody for the treatment of respiratory syncytial virus. The submission is based on data from over 6000 high-risk paediatric patients.